After the purchase concludes, the firm intends to include PRISM Vision into its U.S. Pharmaceutical division subject to ...

MCK is set to acquire a controlling stake in PRISM Vision Holdings, aiming to expand its specialty care capabilities and strengthen its leadership in eye health solutions across the United States.

McKesson expects PRISM Vision to add about 20 cents to 30 cents to its adjusted earnings per share in the first 12 months following the close of the transaction, and then to be between 65 cents and 75 ...

McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM ...

McKesson acquires 80% of PRISM Vision Holdings for $850M, expanding their presence in ophthalmology and retina management services.

McKesson (MCK) signed a definitive agreement to acquire a controlling interest in PRISM Vision Holdings, LLC, a provider of general ...

McKesson inked a deal to buy a controlling interest in Prism Vision Holdings, as it also logged higher profit and revenue in its fiscal third quarter. The drug distributor said Wednesday that it ...

Irving-based McKesson (NYSE: MCK) announced on Feb. 4 an agreement to buy an 80% controlling interest in New Providence, New ...

McKesson Corporation has signed a definitive agreement to acquire an 80% stake in Prism Vision Holdings from Quad-C for approximately $850 million.

Based on our third quarter performance, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.55 to $32.95. We are also pleased to announce the ...

Q3 2025 Earnings Call Transcript February 5, 2025 Operator: Welcome to McKesson’s Third Quarter Fiscal 2025 Earnings ...

IRVING, Texas - McKesson Corporation (NYSE: NYSE:MCK), a $76 billion healthcare giant with "GREAT" financial health according ...